NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080222245

Registered date:03/10/2013

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedUlcerative colitis
Date of first enrollment03/10/2013
Target sample size
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : AJG511 INN of investigational material : budesonide Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : intrarectal

Outcome(s)

Primary OutcomeRemission rate
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 16age old
Age maximum<= 69age old
GenderBoth
Include criteria<Major Inclusion Criteria> Patients with lesions not exceeding the segment from the rectum to the sigmoid colon
Exclude criteria<Major Exclusion Criteria> - Patients with infections and deep mycosis against which no effective antimicrobial is available. - Patients with intolerance to or a history of allergic reaction to budesonide.

Related Information

Contact

Public contact
Name
Address contact_ajis@ajinomoto.com
Telephone
E-mail
Affiliation Ajinomoto Pharmaceuticals Co., Ltd.
Scientific contact
Name
Address contact_ajis@ajinomoto.com
Telephone
E-mail
Affiliation Ajinomoto Pharmaceuticals Co., Ltd.